These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38237348)

  • 1. The regulatory mechanisms of oncomiRs in cancer.
    Otmani K; Rouas R; Berehab M; Lewalle P
    Biomed Pharmacother; 2024 Feb; 171():116165. PubMed ID: 38237348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications.
    Otmani K; Rouas R; Lewalle P
    Front Immunol; 2022; 13():913951. PubMed ID: 36189271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The duality of oncomiR addiction in the maintenance and treatment of cancer.
    Cheng CJ; Slack FJ
    Cancer J; 2012; 18(3):232-7. PubMed ID: 22647359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A step-by-step microRNA guide to cancer development and metastasis.
    Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
    Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
    Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
    BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
    Buechner J; Tømte E; Haug BH; Henriksen JR; Løkke C; Flægstad T; Einvik C
    Br J Cancer; 2011 Jul; 105(2):296-303. PubMed ID: 21654684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis.
    Tomasetti M; Amati M; Santarelli L; Neuzil J
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA biogenesis pathways in cancer.
    Lin S; Gregory RI
    Nat Rev Cancer; 2015 Jun; 15(6):321-33. PubMed ID: 25998712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential.
    Guz M; Jeleniewicz W; Cybulski M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.
    Otmani K; Lewalle P
    Front Oncol; 2021; 11():708765. PubMed ID: 34722255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in Oncogenesis and Tumor Suppression.
    Barbato S; Solaini G; Fabbri M
    Int Rev Cell Mol Biol; 2017; 333():229-268. PubMed ID: 28729026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR221/222 in cancer: their role in tumor progression and response to therapy.
    Garofalo M; Quintavalle C; Romano G; Croce CM; Condorelli G
    Curr Mol Med; 2012 Jan; 12(1):27-33. PubMed ID: 22082479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer.
    Svoronos AA; Engelman DM; Slack FJ
    Cancer Res; 2016 Jul; 76(13):3666-70. PubMed ID: 27325641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-oncomir suppression of tumor phenotypes.
    Goga A; Benz C
    Mol Interv; 2007 Aug; 7(4):199-202, 180. PubMed ID: 17827440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours.
    Leichter AL; Sullivan MJ; Eccles MR; Chatterjee A
    Mol Cancer; 2017 Jan; 16(1):15. PubMed ID: 28103887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA and Metastasis.
    Ma L
    Adv Cancer Res; 2016; 132():165-207. PubMed ID: 27613133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncomirs - microRNAs with a role in cancer.
    Esquela-Kerscher A; Slack FJ
    Nat Rev Cancer; 2006 Apr; 6(4):259-69. PubMed ID: 16557279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.